Mounjaro (Tirzepatide) and Constipation: Why It Happens and What Helps

Tirzepatide, sold in Europe as Mounjaro, has become one of the most prescribed medicines for type 2 diabetes and weight management. It is also one of the most effective. But like the rest of its class, it comes with a digestive trade-off that catches many people off guard, and constipation is near the top of that list.

What makes tirzepatide worth treating on its own terms is that it is not quite the same drug as semaglutide. Tirzepatide is a dual agonist: it activates both the GIP and the GLP-1 receptors, where semaglutide (Ozempic, Wegovy) acts on the GLP-1 receptor alone.¹ The constipation question sits inside the same broader picture as the rest of the category, which we cover in our complete guide to fiber and GLP-1 medications. Here we focus on what the European data says about tirzepatide specifically, and what actually helps.

How common is constipation on tirzepatide?

Common enough that you should plan for it rather than be surprised by it.

The European Medicines Agency classifies constipation as a side effect of tirzepatide that ranges from common to very common, depending on what the drug is being used for.¹ In trials for type 2 diabetes it is “common,” meaning it affects between 1 in 100 and 1 in 10 people. In weight-management, sleep-apnoea and heart-failure trials it is “very common,” meaning it affects at least 1 in 10.¹

For the weight-management population, which is where most people reading this will sit, that puts constipation firmly in the very common category. It is not a rare or unlucky reaction. It is an expected part of how the drug behaves for a meaningful share of users.

One important note on the numbers: overall gastrointestinal side effects rise with dose. In a weight-management trial, gastrointestinal disorders as a whole affected roughly 56% of people on 5 mg, 61% on 10 mg and 59% on 15 mg, compared with about 30% on placebo.¹ Those figures cover all digestive side effects together, not constipation alone, but they show the direction of travel: the higher your dose, the more likely you are to feel it in your gut.

Why does tirzepatide cause constipation?

The same mechanism that helps you eat less is the one that backs things up.

Slower gastric emptying. Tirzepatide delays how quickly food leaves your stomach.¹ This is part of how it reduces appetite, because food sits longer and you feel full sooner. But slower transit through the whole digestive tract means stool spends more time in the colon, where water is steadily reabsorbed. The result is harder, drier, less frequent stool.

Less food, less fiber. When the drug is doing its job, you eat considerably less. Eating less almost always means taking in less fiber, and the average European adult already falls short of fiber recommendations before any appetite suppression enters the picture.² A shrinking plate widens the existing fiber gap.

Less to drink. Reduced appetite often comes with reduced thirst and lower fluid intake. Dehydration makes constipation worse, because the colon pulls even more water out of stool when the body is short on fluid.

These three effects stack. The person whose gut most needs fiber and water is, at exactly the same time, eating and drinking less of both.

When is tirzepatide constipation likely to be worst?

During dose increases.

Tirzepatide is started low and stepped up slowly on purpose. The European label begins at 2.5 mg once weekly, moves to 5 mg after four weeks, and only then increases in 2.5 mg steps, never sooner than every four weeks, up to a maximum of 15 mg.¹ That schedule exists in large part to let the digestive system adjust.

The EMA notes that gastrointestinal side effects are higher during the dose-escalation period and decrease over time.¹ In practice, the weeks right after each step up are when constipation, nausea and related symptoms are most likely to flare. If you know a dose increase is coming, that is the moment to be most deliberate about fiber and fluids, not after symptoms have already taken hold.

What kind of fiber helps with tirzepatide constipation?

Soluble fiber, introduced slowly, with enough water to matter.

Not all fiber behaves the same way. The distinction that counts here is between soluble and insoluble fiber.

Soluble fiber dissolves in water and forms a gel in the gut. It can increase stool frequency by drawing water into the colon, and it feeds beneficial gut bacteria. Psyllium husk, chicory inulin and oat beta-glucan are common examples. Psyllium in particular has a solid evidence base for constipation relief, with clinical work using daily doses in the range of roughly 3.5 to 10.5 grams.³

Insoluble fiber adds bulk and speeds transit in a healthy gut, but for someone whose gastric emptying is already slowed by tirzepatide, piling on bulk without enough water can sometimes make discomfort worse rather than better.

In the European context, chicory inulin is worth singling out because it carries an EU-authorized health claim. Under Commission Regulation (EU) 2015/2314, the legally authorized wording is that chicory inulin contributes to normal bowel function by increasing stool frequency, at a daily intake of 12 grams of native chicory inulin.⁴ That does not make inulin the only valid choice, and it comes with its own tolerance caveat below, but it is a level of regulatory scrutiny most fibers cannot claim. For a fuller comparison of the two leading options, see chicory inulin versus psyllium husk for GLP-1 users.

How do you add fiber without making things worse?

Slowly. This is the part people skip, and it is the part that decides whether fiber helps or backfires.

Chicory inulin is a high-FODMAP fiber, and a full 12-gram dose on day one can cause gas and bloating, especially in a gut already slowed by medication. Psyllium, too, is better tolerated when introduced gradually. The principle is the same across fibers: ramp up.

A reasonable approach is to start at roughly a third of your target dose for the first few days, increase to about two-thirds after three to five days if you are tolerating it, and reach the full dose after another three to five days. A one to two week ramp is normal, and taking longer is fine. The goal is a sustainable daily habit, not a fast finish.

Hydration is not optional. Fiber without enough water can deepen constipation instead of relieving it. Aim for at least 1.5 to 2 litres of fluid a day, with an extra glass alongside each fiber serving. Because tirzepatide can blunt thirst, reminders help more than waiting to feel thirsty. We walk through the gentle-start approach in more detail in how to start a fiber supplement without bloating, and what to look for in a product in our buyer’s guide for GLP-1 users.

Does fiber timing interact with the Mounjaro injection?

Not with the injection itself, but mind your other oral medicines.

Tirzepatide is a once-weekly injection that can be taken at any time of day, with or without food.¹ There is no special timing relationship between the shot and a fiber supplement.

There is, however, one real interaction to respect. Tirzepatide delays gastric emptying and can therefore slow the rate at which oral medicines are absorbed, an effect most pronounced when you first start the drug or step up a dose.¹ Fiber can also slow the absorption of some medications. The practical rule is to take fiber at least two hours apart from other oral medicines, and to speak with your pharmacist if you take a drug with a narrow therapeutic window, such as certain blood thinners.

When should you talk to your doctor?

Fiber and fluids resolve most cases, but some situations need medical input.

If constipation persists beyond two to three weeks despite adequate fiber and hydration, raise it with your prescribing clinician. If you have severe abdominal pain, blood in your stool, vomiting, or a sudden marked change in bowel habits, seek medical advice promptly, since the EMA flags dehydration from gastrointestinal side effects as a risk worth taking seriously.¹

This information is educational and does not replace medical guidance. Fiber supplementation complements your treatment; it is not a substitute for it, and your prescriber is the right person to weigh your full picture.